RecruitingNCT04579471

Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universitaire Ziekenhuizen KU Leuven
Principal Investigator
Jef Verbeek, MD, PhD
UZ Leuven
Intervention
SARS-CoV-2 IgG(diagnostic_test)
Enrollment
2000 target
Eligibility
18-90 years · All sexes
Timeline
20202025

Study locations (1)

Collaborators

KU Leuven · Hasselt University · Ziekenhuis Oost-Limburg · Jessa Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04579471 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials